Skip to content

Brief Cognitive Behavioral Therapy compared with Pharmacotherapy for treating depression and improving well-being in young adults in Pakistan

A quasi-experimental controlled study comparing the effectiveness of Brief Cognitive Behavioral Therapy (individual and group modules) versus pharmacotherapy in reducing depressive symptoms, anxiety, stress, and improving psychological well-being among young adults (18–30 years) in Pakistan

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000894392
Acronym
BCBT-DEP Study
Enrollment
88
Registered
2026-07-20
Start date
2025-05-01
Completion date
2025-08-20
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Depression is a leading cause of disability among young adults worldwide, with high prevalence in Pakistan. This study compares Brief Cognitive Behavioral Therapy (individual and group formats) with pharmacotherapy in reducing depressive symptoms, anxiety, stress, and improving well-being among university students aged 18–30 years. Participants will be assessed at baseline, post-intervention, and follow-up periods to determine the effectiveness of culturally adapted Brief CBT as an accessible treatment option in Pakistan.

Interventions

Intervention Arms: Arm 1: Brief Cognitive Behavioral Therapy – Individual Module • Manual-based Brief CBT (Cully et al., 2020) • 4–8 weekly sessions (60 minutes each) • Face-to-face delivery • Includes psychoeducation, behavioral activation, cognitive restructuring, homework, relapse prevention • Delivered by trained clinical psychologist Arm 2: Brief Cognitive Behavioral Therapy – Group Module • 4–8 weekly sessions (60 minutes) • 20–22 participants per group • Same therapeutic components as ind

Intervention Arms: Arm 1: Brief Cognitive Behavioral Therapy – Individual Module • Manual-based Brief CBT (Cully et al., 2020) • 4–8 weekly sessions (60 minutes each) • Face-to-face delivery • Includes psychoeducation, behavioral activation, cognitive restructuring, homework, relapse prevention • Delivered by trained clinical psychologist Arm 2: Brief Cognitive Behavioral Therapy – Group Module • 4–8 weekly sessions (60 minutes) • 20–22 participants per group • Same therapeutic components as individual module • This study involves a Brief Cognitive Behavioral Therapy (CBT) intervention delivered in two formats: individual and group modules. The intervention is manual based (Cully et al., 2020) and includes core components such as psychoeducation, behavioral activation, cognitive restructuring, and relapse prevention strategies. • The individual module consists of 4–8 weekly face-to-face sessions (60 minutes each) delivered by a trained clinical psychologist. The group module consists of 4–8 weekly sessions (60 minutes each) with approximately 20–22 participants per group, incorporating the same therapeutic components as the individual format. • The intervention will be delivered at a well-established university-based counselling centre with appropriate clinical facilities. • Intervention fidelity and adherence will be monitored using session attendance records, therapist-completed session checklists, and participant homework compliance logs. • Participants will be allocated using a matched allocation procedure based on baseline depression severity scores measured using the Beck Depression Inventory (BDI). Participants with comparable severity levels will be assigned to study arms to ensure baseline equivalence. Allocation will be conducted sequentially following baseline assessment.

Sponsors

University of Haripur
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

• Age 18–30 years • Moderate depression level • University students (Hazara Division) • Provided informed consent

Exclusion criteria

• Severe depression requiring inpatient care • Active suicidal intent • Psychotic disorders • Substance dependence • Severe medical illness

Outcome results

None listed

Source: ANZCTR · Data processed: Aug 10, 2026